This website requires certain cookies to work and uses other cookies to help you have the best experience. By visiting this website, certain cookies have already been set, which you may delete and block. By closing this message or continuing to use our site, you agree to the use of cookies. Visit our updated privacy and cookie policy to learn more.
This Website Uses Cookies By closing this message or continuing to use our site, you agree to our cookie policy. Learn MoreThis website requires certain cookies to work and uses other cookies to help you have the best experience. By visiting this website, certain cookies have already been set, which you may delete and block. By closing this message or continuing to use our site, you agree to the use of cookies. Visit our updated privacy and cookie policy to learn more.
According to a recent report on the COVID-19 outlook and impact on medical marijuana, the cannabis market is poised to grow by $22.33 billion with a CAGR of over 24 percent by 2024. It’s safe to say that within the next decade, the everyday routine of millions of American consumers will integrate some type of cannabis, whether as a functional food and beverage ingredient, a beauty product or as a health or mood aid.
For the time being, however, the cannabis industry remains small, fragmented and somewhat complicated. The legal landscape in the United States surrounding cannabis sales is a patchwork of local laws that are often inconsistent. Furthermore, because flowering marijuana remains a schedule I controlled substance under federal law, interstate commerce is forbidden. The industry is essentially cash-only, scattered and has limited capital investment in automated technologies. For the most part, the industry continues to rely on manual labor for processing and packaging.